XML 23 R38.htm IDEA: XBRL DOCUMENT v3.20.1
Revenue - Summary of Revenues Disaggregated by Product Classification and Operating Segment (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2020
Mar. 31, 2019
Disaggregation Of Revenue [Line Items]        
Total revenue $ 22,822 $ 22,676 $ 45,438 $ 44,917
Product Sales [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 11,770 9,887 21,744 19,638
Royalties [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 8,221 9,932 18,369 20,028
Research, Development and Other [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 2,831 2,857 5,325 5,251
Operating Segments [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 22,822 22,676 45,438 44,917
Operating Segments [Member] | Medical Device [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 16,304 17,301 33,708 34,559
Operating Segments [Member] | Medical Device [Member] | Product Sales [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 5,455 4,558 10,477 9,336
Operating Segments [Member] | Medical Device [Member] | Royalties [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 6,714 8,313 15,613 15,998
Operating Segments [Member] | Medical Device [Member] | Research, Development and Other [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 2,628 2,811 4,862 5,195
Operating Segments [Member] | Medical Device [Member] | License Fees [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 1,507 1,619 2,756 4,030
Operating Segments [Member] | In Vitro Diagnostics [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 6,518 5,375 11,730 10,358
Operating Segments [Member] | In Vitro Diagnostics [Member] | Product Sales [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 6,315 5,329 11,267 10,302
Operating Segments [Member] | In Vitro Diagnostics [Member] | Other [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue $ 203 $ 46 $ 463 $ 56